Prostate Cancer News on BioPortfolio

LIDDS initiates multiple immunooncology feasibility studies

LIDDS has started four internal projects that focus on assessing the feasibility of using the NanoZolid drug delivery technology for local or intratumoral immunotherapy. These feasibility studies will investigate if four different immunomodulatory agen...

Pages